{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T15:10:35Z","timestamp":1702221035960},"reference-count":113,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Gastroenterol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1055\/a-2026-1277","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T22:39:03Z","timestamp":1681252743000},"page":"420-440","source":"Crossref","is-referenced-by-count":2,"title":["S3-Leitlinie Diagnostik und Therapie bili\u00e4rer Karzinome"],"prefix":"10.1055","volume":"61","author":[{"given":"Michael","family":"Bitzer","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Gastrointestinale Onkologie, Hepatologie, Infektiologie und Geriatrie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Gro\u00df","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Gastrointestinale Onkologie, Hepatologie, Infektiologie und Geriatrie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Albert","sequence":"additional","affiliation":[{"name":"Katharinenhospital, Klinik f\u00fcr Allgemeine Innere Medizin, Gastroenterologie, Hepatologie, Infektiologie und Pneumologie, Stuttgart"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Boda-Heggemann","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlentherapie und Radioonkologie, Universit\u00e4tsklinikum Mannheim"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Brunner","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinik f\u00fcr Strahlentherapie-Radioonkologie, Medizinische Universit\u00e4t Graz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Caspari","sequence":"additional","affiliation":[{"name":"Klinik Niederrhein Erkrankungen des Stoffwechsels der\u00a0Verdauungsorgane und Tumorerkrankungen, Bad\u00a0Neuenahr-Ahrweiler"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"De Toni","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Dombrowski","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Universit\u00e4t Greifswald"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Evert","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Universit\u00e4t Regensburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Geier","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik II, Universit\u00e4tsklinikum W\u00fcrzburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Gkika","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Strahlenheilkunde, Department f\u00fcr Radiologische Diagnostik und Therapie, Universit\u00e4tsklinikum Freiburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"G\u00f6tz","sequence":"additional","affiliation":[{"name":"Medizinische Klinik IV \u2013 Gastroenterologie\/Onkologie, Klinikverbund S\u00fcdwest, B\u00f6blingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Helmberger","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Radiologie, Neuroradiologie und minimal invasive Therapie, M\u00fcnchen Klinik Bogenhausen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf-Thorsten","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Institut und Poliklinik f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum Dresden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Huppert","sequence":"additional","affiliation":[{"name":"Radiologisches Zentrum, Max Grundig Klinik, B\u00fchlerh\u00f6he"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achim","family":"Kautz","sequence":"additional","affiliation":[{"name":"Deutsche Leberhilfe e.\u200aV."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Krug","sequence":"additional","affiliation":[{"name":"Strahlentherapie Campus Kiel, Universit\u00e4tsklinikum Schleswig-Holstein"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian La","family":"Foug\u00e8re","sequence":"additional","affiliation":[{"name":"Nuklearmedizin und Klinische Molekulare Bildgebung, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hauke","family":"Lang","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemein-, Viszeral- und Transplantationschirurgie, Johannes Gutenberg-Universit\u00e4t, Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lenz","sequence":"additional","affiliation":[{"name":"Zentrale Einrichtung Palliativmedizin, Universit\u00e4tsklinikum M\u00fcnster"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"L\u00fcdde","sequence":"additional","affiliation":[{"name":"Medizinische Klinik f\u00fcr Gastroenterologie, Hepatologie und Infektiologie, Universit\u00e4tsklinikum D\u00fcsseldorf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Mahnken","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum Marburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Nadalin","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemein-, Viszeral- und Transplantationschrirugie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoa Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Humangenetik, Ruhr-Universit\u00e4t, Bochum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Ockenga","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II, Gesundheit Nord, Klinikverbund Bremen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Oldhafer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Leber-, Gallenwegs- und Pankreaschirurgie, Asklepios Klinik Barmbek"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Paprottka","sequence":"additional","affiliation":[{"name":"Sektion f\u00fcr Interventionelle Radiologie, Klinikum rechts der Isar, Technische Universit\u00e4t M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Pereira","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Radiologie, Minimal-invasive Therapien und Nuklearmedizin, SLK-Klinken Heilbronn"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Persigehl","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, Universit\u00e4tsklinikum K\u00f6ln"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Plentz","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Innere Medizin, Gesundheit Nord, Klinikverbund Bremen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Pohl","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Asklepios Klinik Altona"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Recken","sequence":"additional","affiliation":[{"name":"Hamburger Fern-Hochschule"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reimer","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, St\u00e4dtisches Klinikum Karlsruhe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Riemer","sequence":"additional","affiliation":[{"name":"Lebertransplantierte e.\u200aV."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Ritterbusch","sequence":"additional","affiliation":[{"name":"Hospizarbeit am Universit\u00e4tsklinikum Essen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Roeb","sequence":"additional","affiliation":[{"name":"Medizinische Klinik II Pneumologie, Nephrologie und Gastroenterologie, Universit\u00e4tsklinikum Gie\u00dfen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"R\u00fcssel","sequence":"additional","affiliation":[{"name":"Medizinische Klinik IV H\u00e4matologie und Onkologie, Universit\u00e4tsklinikum Halle (Saale)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Schellhaas","sequence":"additional","affiliation":[{"name":"Medizinische Klinik I Gastroenterologie, Pneumologie und Endokrinologie, Friedrich-Alexander-Universit\u00e4t, Erlangen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[{"name":"Allgemeine Pathologie und pathologische Anatomie, Universit\u00e4tsklinikum Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J\u00fcrgen","family":"Schlitt","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Chirurgie, Universit\u00e4tsklinikum Regensburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Schmid","sequence":"additional","affiliation":[{"name":"Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital, LMU M\u00fcnchen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schuler","sequence":"additional","affiliation":[{"name":"Medizinische Klinik, Gastroenterologie, Alb-Fils-Kliniken, Geislingen an der Steige"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Seehofer","sequence":"additional","affiliation":[{"name":"Klinik und Poliklinik f\u00fcr Viszeral-, Transplantations-, Thorax- und Gef\u00e4\u00dfchirurgie, Universit\u00e4tsklinikum Leipzig"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Sinn","sequence":"additional","affiliation":[{"name":"II. Medizinische Klinik und Poliklinik (Onkologie, H\u00e4matologie, Knochenmarktransplantation mit Abteilung f\u00fcr Pneumologie), Universit\u00e4tsklinikum Hamburg-Eppendorf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Stengel","sequence":"additional","affiliation":[{"name":"Innere Medizin VI \u2013 Psychosomatische Medizin und Psychotherapie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Stoll","sequence":"additional","affiliation":[{"name":"Klinik Herzogh\u00f6he Bayreuth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tannapfel","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Pathologie, Ruhr-Universit\u00e4t Bochum"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Taubert","sequence":"additional","affiliation":[{"name":"Klinische Sozialarbeit, Universit\u00e4tsklinikum Heidelberg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reina","family":"Tholen","sequence":"additional","affiliation":[{"name":"Deutscher Bundesverband f\u00fcr Physiotherapie (ZVK) e.\u200aV."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Trojan","sequence":"additional","affiliation":[{"name":"Medizinische Klinik 1: Gastroenterologie und Hepatologie, Pneumologie und Allergologie, Endokrinologie und Diabetologie sowie Ern\u00e4hrungsmedizin, Goethe-Universit\u00e4t, Frankfurt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"van Thiel","sequence":"additional","affiliation":[{"name":"Deutsche Leberhilfe e.\u200aV."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vogl","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, Goethe-Universit\u00e4t, Frankfurt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Wacker","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Diagnostische und Interventionelle Radiologie, Medizinische Hochschule Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Waidmann","sequence":"additional","affiliation":[{"name":"Onkologie Bethanien, Frankfurt am Main"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Wege","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Allgemeine Innere Medizin, Onkologie\/H\u00e4matologie, Gastroenterologie und Infektiologie, Klinikum Esslingen"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dane","family":"Wildner","sequence":"additional","affiliation":[{"name":"Innere Medizin, Krankenh\u00e4user N\u00fcrnberger Land GmbH, Standort Lauf"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus-Alexander","family":"W\u00f6rns","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Gastroenterologie, H\u00e4matologie und internistische Onkologie und Endokrinologie, Klinikum Dortmund"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Galle","sequence":"additional","affiliation":[{"name":"1. Medizinische Klinik und Poliklinik, Gastroenterologie, Hepatologie, Nephrologie, Rheumatologie, Infektiologie, Johannes Gutenberg-Universit\u00e4t, Mainz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar","family":"Malek","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Gastroenterologie, Gastrointestinale Onkologie, Hepatologie, Infektiologie und Geriatrie, Eberhard-Karls Universit\u00e4t, T\u00fcbingen"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"J Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jvh.12727","article-title":"Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score","volume":"24","author":"W P Brouwer","year":"2017","journal-title":"J Viral Hepat"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"G Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/dji040","article-title":"Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan","volume":"97","author":"M Inoue","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/CEJ.0000000000000252","article-title":"Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies","volume":"26","author":"F Bravi","year":"2017","journal-title":"Eur J Cancer Prev"},{"issue":"06","key":"ref6","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3945\/ajcn.115.116095","article-title":"The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition","volume":"102","author":"K Aleksandrova","year":"2015","journal-title":"Am J Clin Nutr"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.gastro.2014.10.005","article-title":"Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort","volume":"148","author":"V W Setiawan","year":"2015","journal-title":"Gastroenterology"},{"issue":"07","key":"ref8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"B H Zhang","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/apt.12370","article-title":"Surveillance for hepatocellular cancer with ultrasonography vs. computed tomography \u2013 a randomised study","volume":"38","author":"C Pocha","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/hep.24545","article-title":"Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities","volume":"54","author":"J C Trinchet","year":"2011","journal-title":"Hepatology"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis","volume":"154","author":"K Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2019.07.033","article-title":"Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores","volume":"157","author":"G N Ioannou","year":"2019","journal-title":"Gastroenterology"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/MEG.0000000000001226","article-title":"Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy","volume":"30","author":"B G Song","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.30823","article-title":"Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents","volume":"71","author":"F Kanwal","year":"2020","journal-title":"Hepatology"},{"issue":"09","key":"ref15","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/liv.13142","article-title":"Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis","volume":"36","author":"E Raffetti","year":"2016","journal-title":"Liver Int"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"G V Papatheodoridis","year":"2015","journal-title":"J Hepatol"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease","volume":"155","author":"F Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2147\/CLEP.S144368","article-title":"Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes","volume":"9","author":"J C Simeone","year":"2017","journal-title":"Clin Epidemiol"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jmri.22588","article-title":"Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging","volume":"34","author":"H Haradome","year":"2011","journal-title":"J Magn Reson Imaging"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.1840380430","article-title":"MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation","volume":"38","author":"M Burrel","year":"2003","journal-title":"Hepatology"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00330-012-2691-z","article-title":"Hepatocellular carcinoma in cirrhotic patients: prospective comparison of US, CT and MR imaging","volume":"23","author":"M Di Martino","year":"2013","journal-title":"Eur Radiol"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2010.07.025","article-title":"Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization","volume":"54","author":"K Khalili","year":"2011","journal-title":"J Hepatol"},{"issue":"06","key":"ref23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1477-2574.2012.00617.x","article-title":"Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system","volume":"15","author":"A C Chan","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire","volume":"31","author":"S Chevret","year":"1999","journal-title":"J Hepatol"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade","volume":"33","author":"P J Johnson","year":"2015","journal-title":"J Clin Oncol"},{"issue":"S 01","key":"ref26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000173428","article-title":"Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score","volume":"75","author":"S Kitai","year":"2008","journal-title":"Oncology"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.10384","article-title":"Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients","volume":"94","author":"T W Leung","year":"2002","journal-title":"Cancer"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort","volume":"41","author":"J A Marrero","year":"2005","journal-title":"Hepatology"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","article-title":"The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma","volume":"66","author":"D J Pinato","year":"2017","journal-title":"J Hepatol"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.transproceed.2009.03.054","article-title":"Validation of the BCLC prognostic system in surgical hepatocellular cancer patients","volume":"41","author":"A Vitale","year":"2009","journal-title":"Transplant Proc"},{"issue":"07","key":"ref31","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"T Yau","year":"2014","journal-title":"Gastroenterology"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Management of hepatocellular carcinoma","volume":"69","author":"EASL Clinical Practice Guidelines","year":"2018","journal-title":"J Hepatol"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/00365521.2016.1236396","article-title":"Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis","volume":"52","author":"X Huang","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/hep.29485","article-title":"Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis","volume":"67","author":"L Kulik","year":"2018","journal-title":"Hepatology"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/TP.0000000000001936","article-title":"Systematic Review and Meta-Analysis of Posttransplant Hepatic Artery and Biliary Complications in Patients Treated With Transarterial Chemoembolization Before Liver Transplantation","volume":"102","author":"D Sneiders","year":"2018","journal-title":"Transplantation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.suronc.2019.10.006","article-title":"Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium","volume":"33","author":"H Degroote","year":"2020","journal-title":"Surg Oncol"},{"issue":"09","key":"ref37","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.24169","article-title":"Downstaging hepatocellular carcinoma: A systematic review and pooled analysis","volume":"21","author":"N D Parikh","year":"2015","journal-title":"Liver Transpl"},{"issue":"13","key":"ref38","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"J Bruix","year":"2015","journal-title":"Lancet Oncol"},{"issue":"07","key":"ref39","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2015.02.055","article-title":"Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma","volume":"148","author":"J H Lee","year":"2015","journal-title":"Gastroenterology"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/hep.21415","article-title":"Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis","volume":"44","author":"V Mazzaferro","year":"2006","journal-title":"Hepatology"},{"issue":"01","key":"ref41","first-page":"Cd001199","article-title":"Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma","author":"M Samuel","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0140-6736(00)02654-4","article-title":"Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial","volume":"356","author":"T Takayama","year":"2000","journal-title":"Lancet"},{"issue":"03","key":"ref43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.sla.0000201480.65519.b8","article-title":"A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma","volume":"243","author":"M S Chen","year":"2006","journal-title":"Ann Surg"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","article-title":"A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma","volume":"57","author":"K Feng","year":"2012","journal-title":"J Hepatol"},{"issue":"06","key":"ref45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc656","article-title":"A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria","volume":"252","author":"J Huang","year":"2010","journal-title":"Ann Surg"},{"issue":"13","key":"ref46","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/bjs.10677","article-title":"Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma","volume":"104","author":"K KC Ng","year":"2017","journal-title":"Br J Surg"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2014.03.012","article-title":"Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT","volume":"61","author":"L Yin","year":"2014","journal-title":"J Hepatol"},{"issue":"01","key":"ref48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"R Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"03","key":"ref49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/jgh.12791","article-title":"Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial","volume":"30","author":"G G Di Costanzo","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"03","key":"ref50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.dld.2013.10.015","article-title":"An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma","volume":"46","author":"A Cucchetti","year":"2014","journal-title":"Dig Liver Dis"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JCO.2012.42.9936","article-title":"Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial","volume":"31","author":"Z W Peng","year":"2013","journal-title":"J Clin Oncol"},{"issue":"04","key":"ref52","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/bjs.10061","article-title":"Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria","volume":"103","author":"H Liu","year":"2016","journal-title":"Br J Surg"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1080\/00365521.2018.1548645","article-title":"Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma","volume":"53","author":"K Endo","year":"2018","journal-title":"Scand J Gastroenterol"},{"issue":"05","key":"ref54","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"C M Lo","year":"2002","journal-title":"Hepatology"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"J Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/bjc.2014.199","article-title":"Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma","volume":"111","author":"R Golfieri","year":"2014","journal-title":"Br J Cancer"},{"issue":"01","key":"ref57","first-page":"Cd011313","article-title":"Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma","volume":"1","author":"O Abdel-Rahman","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"08","key":"ref58","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/s-0043-124870","article-title":"Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial","volume":"50","author":"J Yang","year":"2018","journal-title":"Endoscopy"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s00330-016-4548-3","article-title":"Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus (90)Y-radioembolization for hepatocellular carcinoma","volume":"27","author":"J M Ludwig","year":"2017","journal-title":"Eur Radiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.2147\/OTT.S175715","article-title":"Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: a meta-analysis of randomized trials","volume":"11","author":"G A Casadei","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"11","key":"ref61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"V Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"issue":"01","key":"ref62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"V Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"issue":"06","key":"ref63","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"F Y Yao","year":"2001","journal-title":"Hepatology"},{"issue":"04","key":"ref64","first-page":"2379","article-title":"Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis","volume":"13","author":"A Facciorusso","year":"2021","journal-title":"Am J Transl Res"},{"issue":"20","key":"ref65","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"R S Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"01","key":"ref66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"A L Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"M Kudo","year":"2018","journal-title":"The Lancet"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"J Bruix","year":"2017","journal-title":"The Lancet"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMoa1717002","article-title":"Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma","volume":"379","author":"G K Abou-Alfa","year":"2018","journal-title":"N Engl J Med"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1470-2045(18)30937-9","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased \u03b1-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"A X Zhu","year":"2019","journal-title":"Lancet Oncol"},{"issue":"04","key":"ref71","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"J M Llovet","year":"2008","journal-title":"N Engl J Med"},{"issue":"06","key":"ref72","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2016.07.020","article-title":"Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study","volume":"65","author":"J A Marrero","year":"2016","journal-title":"J Hepatol"},{"issue":"19","key":"ref73","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1158\/1078-0432.CCR-16-0919","article-title":"Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study","volume":"23","author":"T M Ganten","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"05","key":"ref74","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10637-018-0621-x","article-title":"Survival and tolerance to sorafenib in Child-Pugh B patients with hepatocellular carcinoma: a prospective study","volume":"36","author":"C RG Leal","year":"2018","journal-title":"Invest New Drugs"},{"issue":"02","key":"ref75","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/annonc\/mds343","article-title":"Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis","volume":"24","author":"T Pressiani","year":"2013","journal-title":"Ann Oncol"},{"issue":"03","key":"ref76","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10637-015-0237-3","article-title":"Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors","volume":"33","author":"S Ogasawara","year":"2015","journal-title":"Invest New Drugs"},{"issue":"12","key":"ref77","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"V Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"issue":"19","key":"ref78","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","article-title":"SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma","volume":"36","author":"P KH Chow","year":"2018","journal-title":"J Clin Oncol"},{"issue":"05","key":"ref79","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2016.01.012","article-title":"Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial","volume":"64","author":"R Lencioni","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"08","key":"ref80","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S2468-1253(17)30156-5","article-title":"Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial","volume":"2","author":"T Meyer","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","article-title":"Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"389","author":"J Bruix","year":"2017","journal-title":"Lancet"},{"key":"ref83","first-page":"CD011129","article-title":"Early palliative care for adults with advanced cancer","volume":"6","author":"M W Haun","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"09","key":"ref84","first-page":"660","article-title":"[Integration of palliative care into intensive care: Systematic review]","volume":"66","author":"K Adler","year":"2017","journal-title":"Anaesthesist"},{"issue":"06","key":"ref85","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S1478951513001338","article-title":"Early integration of palliative care in hospitals: A systematic review on methods, barriers, and outcome","volume":"12","author":"K M Dalgaard","year":"2014","journal-title":"Palliat Support Care"},{"issue":"03","key":"ref86","first-page":"99","article-title":"A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses","volume":"4","author":"M P Davis","year":"2015","journal-title":"Ann Palliat Med"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1634\/theoncologist.2014-0312","article-title":"Integration of oncology and palliative care: a\u00a0systematic review","volume":"20","author":"D Hui","year":"2015","journal-title":"Oncologist"},{"issue":"07","key":"ref88","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1634\/theoncologist.2016-0006","article-title":"Referral Criteria for Outpatient Palliative Cancer Care: A Systematic Review","volume":"21","author":"D Hui","year":"2016","journal-title":"Oncologist"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1574887110666151014141650","article-title":"Early Palliative Care in Advanced Oncologic and Non-Oncologic Chronic Diseases: A Systematic Review of Literature","volume":"11","author":"D Tassinari","year":"2016","journal-title":"Rev Recent Clin Trials"},{"issue":"08","key":"ref90","first-page":"501","article-title":"[Physical complaints, stress and quality of life of oncologic patients. Effects and patient assessment in inpatient rehabilitation]","volume":"91","author":"U G\u00e4rtner","year":"1996","journal-title":"Med Klin (Munich)"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.25362","article-title":"Risk of cancer in a large cohort of U.S. veterans with diabetes","volume":"128","author":"E A Atchison","year":"2011","journal-title":"Int J Cancer"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1478-3231.2011.02614.x","article-title":"Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort","volume":"32","author":"M B de Valle","year":"2012","journal-title":"Liver Int"},{"issue":"01","key":"ref93","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.22606","article-title":"Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.\u200aS. veterans","volume":"49","author":"H B El-Serag","year":"2009","journal-title":"Hepatology"},{"issue":"59","key":"ref94","doi-asserted-by":"crossref","first-page":"100570","DOI":"10.18632\/oncotarget.20141","article-title":"Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis","volume":"8","author":"Y Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CEJ.0b013e3283481d89","article-title":"Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis","volume":"21","author":"W Jing","year":"2012","journal-title":"Eur J Cancer Prev"},{"issue":"01","key":"ref96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"W C Palmer","year":"2012","journal-title":"J Hepatol"},{"issue":"01","key":"ref97","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","article-title":"Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis","volume":"17","author":"N Wongjarupong","year":"2017","journal-title":"BMC Gastroenterol"},{"issue":"02","key":"ref98","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1440-1746.2008.05689.x","article-title":"Long-term follow up of gallbladder polyps","volume":"24","author":"J Y Park","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"08","key":"ref99","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/apt.12655","article-title":"Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer","volume":"39","author":"V Nagaraja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref100","first-page":"497942","article-title":"Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"2015","author":"H Zhang","year":"2015","journal-title":"Biomed Res Int"},{"issue":"01","key":"ref101","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/2303-9027.193597","article-title":"Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: Systematic review and meta-analysis","volume":"7","author":"D TH De Moura","year":"2018","journal-title":"Endosc Ultrasound"},{"issue":"04","key":"ref102","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.gie.2015.04.030","article-title":"Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review","volume":"82","author":"U Navaneethan","year":"2015","journal-title":"Gastrointest Endosc"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-007-0335-4","article-title":"Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period","volume":"12","author":"N S Becker","year":"2008","journal-title":"J Gastrointest Surg"},{"issue":"01","key":"ref104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Murad S Darwish","year":"2012","journal-title":"Gastroenterology"},{"issue":"05","key":"ref105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00270-021-02800-w","article-title":"Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis","volume":"44","author":"C Mosconi","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.2147\/OTT.S202875","article-title":"A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma","volume":"12","author":"Y Zhen","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"05","key":"ref107","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"J N Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"07","key":"ref108","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3390\/cancers12071975","article-title":"Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial","volume":"12","author":"A Markussen","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"14","key":"ref109","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"J Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"04","key":"ref110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","article-title":"Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan","volume":"103","author":"T Okusaka","year":"2010","journal-title":"Br J Cancer"},{"issue":"02","key":"ref111","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"J W Valle","year":"2014","journal-title":"Ann Oncol"},{"issue":"03","key":"ref112","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4143\/crt.2014.308","article-title":"Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review","volume":"47","author":"J O Park","year":"2015","journal-title":"Cancer Res Treat"},{"issue":"05","key":"ref113","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"G K Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"05","key":"ref114","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"A Lamarca","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["Zeitschrift f\u00fcr Gastroenterologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2026-1277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T14:57:04Z","timestamp":1702220224000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2026-1277"}},"subtitle":["Kurzversion"],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":113,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2023,4,11]]},"published-print":{"date-parts":[[2023,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2026-1277","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0044-2771","1439-7803"],"issn-type":[{"value":"0044-2771","type":"print"},{"value":"1439-7803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}